Titan Pharmaceuticals, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2022-02-07: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2022-02-04; Total offering amount $7,019,570.
- 2021-01-21: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2021-01-20; Total offering amount $9,673,750.
- 2020-01-09: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2020-01-09; Total offering amount $2,175,000.
- 2019-08-19: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2019-08-09; Total offering amount $2,125,512.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2022-02-07 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired | 2022-02-04 | $7,019,570 | $1,520,669 | $5,498,901 | 1 |
| 2021-01-21 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired | 2021-01-20 | $9,673,750 | $9,673,750 | $0 | 7 |
| 2020-01-09 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired | 2020-01-09 | $2,175,000 | $2,175,000 | $0 | 5 |
| 2019-08-19 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired | 2019-08-09 | $2,125,512 | $2,125,512 | $0 | 1 |